What Eli Lilly’s psychedelic investment could mean for the emerging field
The move may be a sign that Big Pharma companies are becoming more comfortable with the once-stigmatized field.
Evolution of drug discovery & development within the healthcare landscape, featuring sharp analysis and essential updates on the latest industry news.
The move may be a sign that Big Pharma companies are becoming more comfortable with the once-stigmatized field.
The drugmakers are looking for ways to make the medicines more effective, and to expand their reach beyond weight loss and diabetes.
It’s one of a growing number of partnerships between the pharmaceutical and, tech industries.
The partnership will allow the drug company new access to key data.
It’s one of a growing number of pharma-tech partnerships.
Spruce Biosciences saw its stock soar after months of decline, thanks to a new drug for a rare disease.
A hot new bombshell has entered the villa…
Healthcare Brew covers pharmaceutical developments, health startups, the latest tech, and how it impacts hospitals and providers to keep administrators and providers informed.
By subscribing, you accept our Terms & Privacy Policy.